查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1861937

超音波切片检查设备市场按产品类型、产品供应、最终用户、应用和适应症划分－2025-2032年全球预测

Endobronchial Ultrasound Biopsy Devices Market by Product Type, Product Offering, End User, Application, Indication - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，支气管内超音波切片检查设备市场规模将达到 11.07 亿美元，复合年增长率为 5.95%。

关键市场统计数据
基准年 2024 6.9715亿美元
预计年份：2025年 7.3874亿美元
预测年份 2032 11.07亿美元
复合年增长率 (%) 5.95%

全面概述超音波切片检查技术的临床价值、技术基础和影响其应用的策略因素

超音波切片检查装置已成为现代呼吸系统疾病诊疗中的关键诊断手段，它将影像学检查和组织取样整合于单一操作流程中。这些装置结合了支气管镜检查和超音波影像，能够更精准地定位和取样纵隔及周围肺部病变。临床医生正在采用这项技术，以提高诊断准确率，减少重复检查，并支持肿瘤科、感染疾病和间质性肺病科等多学科团队的决策。

技术已从基础超音波探头发展到如今的整合系统，这些系统注重人体工学、更高的成像精度以及可降低交叉感染风险的一次性耗材。随着手术流程的不断改进，支付方和医院系统不仅日益重视设备效能，还关注吞吐量、库存复杂性和生命週期成本。因此，采购部门和临床团队在购买或更新超音波平台时，必须考虑设备的互通性、训练要求以及上市后监测数据。

本文概述了临床价值提案、成像和切片检查能力的融合以及医疗机构在评估对超音波切片检查技术的投资时应考虑的战略因素，为后续分析技术变革、监管影响和供应链因素如何共同影响技术的采用和临床整合奠定了基础。

新兴技术进步和临床工作流程的变革正在重新定义超音波切片检查的准确性、安全性和操作整合性。

近年来，支气管内超音波切片检查设备领域发生了变革性变化，这反映了影像解析度的提高、一次性耗材策略的推广以及复杂手术向门诊的转移。探头设计和讯号处理的改进使得病灶和淋巴结的显像更加清晰，从而能够更精准地进行经支气管针吸活检，并减少非诊断性检体的获取。同时，製造商优先开发一次性针头套装和保护鞘套，以简化消毒流程并降低交叉感染的风险，这在后疫情时代的临床管治中尤其重要。

此外，整合影像工作站和内视镜系统的进步提高了资料收集能力，并促进了与电子健康记录和手术记录的整合。这些进步透过提供高解析度影像和切片检查元资料，为多学科肿瘤委员会提供支持，从而指导长期治疗决策。此外，技术在门诊手术中心和专科诊所的普及也反映了手术报销结构的变化以及在控製成本的同时提高患者吞吐量的努力。

基于人工智慧的影像和手术指导将进一步变革临床工作流程，提高病灶标靶化的准确性并规范采样策略。因此，相关人员需要调整培训课程、完善认证架构并重新评估资本规划，以适应以精准性、安全性和营运效率为优先的新情势。

美国关税调整导致供应链韧性和筹资策略重塑，推动了设备生态系统内供应商多元化和区域化生产。

2025年美国关税调整的累积影响正波及全球医疗设备供应链，迫使製造商和医疗服务提供者重新评估其超音波切片检查设备的筹资策略。关税导致进口零件成本上升，推高了製造成本，尤其是那些依赖跨境生产关键子组件和专用超音波换能器的公司。为因应这项挑战，各公司正在加速供应商多元化，尽可能转向区域供应商，并在某些情况下重新调整本地製造投资的优先级，以降低未来政策变化带来的风险。

在临床采购方面，对关税风险的高度重视促使医院系统和集团采购组织协商长期供应协议，并在采购决策中强调整体拥有成本。这些谈判越来越重视耗材供应和售后支持，将其视为设备价值的关键因素。同时，製造商也在寻求透过流程改善、精益生产实践以及减少对受关税影响的原材料依赖的设计选择来分担部分成本负担。

最后，监管和合约团队越来越重视取证要求。对于相关人员，关税情势凸显了情境规划、多元化供应商网路以及包含成本转嫁条款的合约的重要性，以确保能够稳定地获得超音波切片检查设备及相关耗材。

详细的细分观点揭示了产品类型、功能、最终用户、应用和临床适应症如何独特地影响设备的选择和采用。

市场区隔分析从产品类型、产品组合、最终用户、应用和临床适应症等角度检验市场，揭示清晰的性能驱动因素和市场推广路径。在产品类型方面，可区分使用纵向探针（能够直接观察纵膈和肺门淋巴结的针吸切片检查）和径向探针（能够更精准地定位外周病灶并支持辅助诊断策略）的设备。在产品组合方面，影像工作站和内视镜系统等设备投资构成资本规划和整合成本的基础，而针组和保护鞘套等耗材则影响经常性支出和手术量。

终端用户环境进一步影响了采用趋势：门诊手术中心优先考虑紧凑高效的系统和精简的耗材，以支持高通量门诊手术；医院重视先进的成像功能、广泛的设备互通性和全面的服务协议；专科诊所则寻求兼顾诊断性能、空间和人员限制的经济高效的配置。应用范围涵盖纵隔分期（需要高精度和可重复性）、週边病变诊断（病变可及性和图像分辨率至关重要）以及经支气管针吸切片检查（结合成像和组织采集，重点关注针头设计和采样效率）。

最后，从癌症诊断到感染疾病评估再到类肉瘤病病评估等临床适应症，都会影响设备的选择和通讯协定，因为组织合格、样本处理和下游分子检测要求在这些诊断途径之间差异很大。

区域采用模式和商业性需求将影响部署、培训和售后市场策略。

区域趋势对美洲、欧洲、中东和非洲以及亚太地区的采用模式、监管预期和商业策略产生了显着影响。在美洲，高技能的三级医疗中心和强大的介入肺科计画集中分布，推动了整合影像工作站和先进内视镜系统的早期应用；同时，支付方也越来越检验手术流程的成本效益和治疗结果的一致性。向门诊手术环境的转变催生了新的采购重点，这些重点围绕着移动性、易操作性和耗材生命週期管理。

在欧洲、中东和非洲地区，由于法规环境和医院资金筹措模式的差异，医疗设备部署呈现以医院为中心和以专科诊所为主导的混合模式。製造商通常会根据各国的医保报销体係以及与区域临床协会的培训合作关係来制定打入市场策略。在亚太地区，都市区三级医疗中心加速采用医疗设备以及癌症诊断基础设施投资带来的装机量成长尤为显着。本地生产和区域经销伙伴在成本控制和服务应对力发挥关键作用。

这些地区的通用趋势包括：重视临床医师训练、重视服务和保障体系，以及耗材管理在维持检测量上的策略角色。因此，在规划市场进入或扩张时，决策者应评估每个地区的监管路径、报销细则和当地临床实践模式。

竞争格局分析突显了多种策略模式，从整合平台供应商到耗材专家，并揭示了这些模式对采购和临床应用的影响。

支气管内超音波切片检查生态系统中的主要企业展现出多元化的策略策略，涵盖从平台整合式解决方案到以耗材为中心的经营模式。现有内视镜製造商专注于系统层面的差异化，将高解析度成像工作站与模组化内视镜架构相结合，以掌控手术生态系统并推动耗材辅助产品的销售。这些公司强调长期服务协议、临床医生培训项目以及捆绑式解决方案，以促进医院整合并简化采购谈判。

同时，针头系统和保护鞘套的专业製造商正优先研发以采样可靠性、组织完整性和一次性使用便利性为核心的技术。他们的商业策略以临床证据为中心，这些证据能够证明诊断率的提高和再次手术率的降低，并辅以针对介入性肺科医生和细胞病理学团队的专项教育倡议。新参与企业和细分领域的创新者则专注于导航辅助设备、切片检查钳和人工智慧影像增强技术等配套技术，并寻求与平台公司建立策略合作伙伴关係，以加速临床应用。

整体而言，竞争格局取决于两类供应商之间的平衡：一类是能够确保持续耗材收入的整合平台，另一类是能够提供临床效能优势和高性价比一次性产品设计的专业供应商。对于买家而言，这种情况使得评估整体合约安排、服务水准协议以及互通性和软体支援的长期发展蓝图显得尤为重要。

为製造商和医疗保健提供者提供切实可行、影响深远的策略行动，以加速临床应用、增强供应链韧性并提升设备的长期价值。

产业领导者若想巩固市场地位并支持永续的临床应用，应采取切实可行的策略，使创新与营运实际情况相契合。首先，应优先考虑内视镜系统与影像工作站之间的端到端集成，以实现无缝的临床工作流程，并减轻临床医生在诊疗现场的负担。其次，引入完善的培训课程和基于模拟的认证，将有助于提高操作熟练度，最大限度地减少切片检查技术的差异，从而提升检体品质和临床医生的信心。

第二，我们建立具有韧性的供应链，透过多元化零件采购，并在条件允许的地区投资製造和组装能力，降低贸易和关税风险。第三，我们提供灵活的采购方案，以因应资金限制（例如，影像工作站的订阅模式结合可预测的耗材价格），并使商业模式与临床工作流程相符。第四，我们致力于收集上市后证据，以证明我们的设备对诊断率、后续治疗决策和病患体验的影响，从而为医保报销谈判和医院药品目录的纳入提供支持。

最后，透过促进互通性和开放资料架构，并实现与电子健康记录和跨专业护理平台的集成，这些努力将共同扩大获得先进的支气管内超音波切片检查能力的机会，同时帮助公司和医疗系统应对不断变化的临床期望、监管审查和财务压力。

我们进行了一项严谨的混合调查方法，结合专家访谈、临床文献回顾和三角资料分析，以检验研究结果并减少偏差。

本分析的调查方法结合了严谨的一手和二手研究技术，以确保分析的深度和有效性。一手资料收集包括对介入性肺科医生、生物医学工程师、采购人员和医院管理人员进行结构化访谈，以了解他们在设备性能、培训需求和耗材物流的真实经验。这些专家的意见为评估临床工作流程、设备人体工学和手术瓶颈提供了基础。

二次研究回顾了同行评审的临床文献、医疗器材附加檔和监管申报文件、临床学会指南以及已发布的监管通告，以支持安全性和有效性声明并描绘技术发展趋势。数据三角验证确保研究结果反映了来自多个资讯来源的趋同证据，并在专家意见存在分歧时进行了敏感性分析。细分市场定义和区域分析的建构与临床实务模式、报销架构和供应链地理相一致。

本调查方法的限制包括监管环境的变化和技术创新的快速发展，这两者都会影响医疗设备的功能和应用。为解决此问题，研究团队在解读新兴技术时格外谨慎，并优先考虑现有的同侪审查证据。伦理方面的考虑包括对访谈参与者进行匿名处理，并征得他们的同意后，方可将他们的个人发现用于汇总分析。

整合策略要点，重点在于突显技术进步、供应链调整和协作临床策略，以最大限度地提高诊断效果

总之，支气管内超音波切片检查设备在诊断准确性、手术安全性和操作效率方面占据战略地位。探头设计、影像工作站和一次性耗材的技术创新正在提高诊断效能，同时也正在重塑门诊手术中心、医院和专科诊所的手术操作方式。同时，关税和不断变化的报销政策等外部压力正迫使製造商和供应商重新思考其采购、定价和商业化模式。

成功推广应用需要从整体观点，考虑设备互通性、临床医生培训、耗材生命週期管理以及上市后证据的产生。透过将产品开发与实际临床工作流程结合，并建立稳健的供应链，相关人员可以加快推广应用，同时控制整体拥有成本并满足监管要求。最终，整合平台与高性能耗材之间的平衡将决定医疗机构如何制定采购决策，以及临床医生如何提供一致、高品质的诊断结果。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 扩大使用即时影像引导的线性支气管内超音波设备以提高淋巴结取样准确性
  • 开发一次性超音波探头，以降低支气管内切片检查术中的感染风险和消毒成本
  • 针头设计的进步，包括可变规格和可调节硬度，可改善EBUS切片检查过程中对气道病变的进入。
  • 在EBUS检查过程中，扩大人工智慧和机器学习演算法在淋巴结自动检测和恶性肿瘤预测的应用。
  • 扩建配备 EBUS 和内视镜导航支气管镜系统的混合手术室，以简化诊断和治疗流程。
  • 医疗设备製造商与软体公司合作开发云端基础的EBUS资料管理和远距教学平台
  • 为安全取得更大组织样本以诊断间质性肺疾病，对微创EBUS引导下切片检查技术的需求日益增长。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8.超音波切片检查设备市场（依产品类型划分）

  • 线性探针
  • 径向探针

9.超音波切片检查设备市场（依产品类型划分）

  • 消耗品
    • 针具套装
    • 保护鞘套
  • 装置
    • 影像工作站
    • 内视镜系统

第十章超音波切片检查设备市场（依最终用户划分）

  • 门诊手术中心
  • 医院
  • 专科诊所

第十一章超音波切片检查设备市场（依应用领域划分）

  • 纵膈分期
  • 週边病变诊断
  • 经支气管针吸切片检查

第十二章超音波切片检查设备市场（依适应症划分）

  • 癌症诊断
  • 感染疾病
  • 类肉瘤病

第十三章 各地区超音波切片检查设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章超音波切片检查设备市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国超音波切片检查设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Olympus Corporation
    • Fujifilm Holdings Corporation
    • HOYA Corporation
    • Boston Scientific Corporation
    • Medtronic plc
    • Karl Storz SE & Co. KG
Product Code: MRR-521BAA36EA81

The Endobronchial Ultrasound Biopsy Devices Market is projected to grow by USD 1,107.00 million at a CAGR of 5.95% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 697.15 million
Estimated Year [2025] USD 738.74 million
Forecast Year [2032] USD 1,107.00 million
CAGR (%) 5.95%

Comprehensive overview of clinical value, technological underpinnings, and strategic factors shaping adoption of endobronchial ultrasound biopsy technologies

Endobronchial ultrasound biopsy devices have emerged as a pivotal diagnostic modality within modern pulmonary care, bridging imaging and tissue acquisition in a single procedural workflow. These devices combine bronchoscopic access with real-time ultrasound visualization to improve localization and sampling of mediastinal and peripheral pulmonary lesions. Clinicians deploy the technology to enhance diagnostic yield, reduce repeat procedures, and support multidisciplinary decision-making across oncology, infectious disease, and interstitial lung disease programs.

Technologically, the field has matured from foundational ultrasound probes to integrated systems that emphasize ergonomics, imaging fidelity, and single-use consumables that lower cross-contamination risk. As procedural pathways evolve, payers and hospital systems increasingly evaluate not just device performance but also throughput, inventory complexity, and lifecycle costs. Consequently, procurement and clinical teams must consider device interoperability, training requirements, and post-market surveillance data when adopting or upgrading endobronchial ultrasound platforms.

This introduction frames the clinical value proposition, the convergence of imaging and biopsy capabilities, and the strategic considerations that healthcare organizations should weigh when assessing investment in endobronchial ultrasound biopsy technology. It sets the stage for subsequent analysis of technological shifts, regulatory influences, and supply chain factors that collectively shape adoption and clinical integration.

Emerging technological advancements and clinical workflow metamorphoses that are redefining precision, safety, and operational integration of endobronchial ultrasound biopsy care

Recent transformative shifts in the landscape of endobronchial ultrasound biopsy devices reflect advances in imaging resolution, single-use consumable strategies, and the migration of complex procedures into ambulatory settings. Improved probe design and signal processing have sharpened visualization of lesions and lymph nodes, enabling more precise transbronchial needle aspiration and reducing nondiagnostic samples. Simultaneously, manufacturers have prioritized disposable needle sets and protective sheaths that streamline sterilization workflows and mitigate cross-infection risks, which is particularly salient in post-pandemic clinical governance.

Concurrently, the evolution of integrated imaging workstations and scope systems has enhanced data capture, enabling smoother integration with electronic health records and procedural documentation. These developments support multidisciplinary tumor boards by delivering higher-fidelity images and biopsy metadata for longitudinal care decisions. In addition, the diffusion of the technology into ambulatory surgical centers and specialty clinics reflects procedural reimbursement shifts and efforts to improve patient throughput while containing costs.

Looking forward, artificial intelligence-assisted image interpretation and procedural guidance are likely to further alter clinician workflows, improving lesion targeting and standardizing sampling strategies. As a result, stakeholders must adapt training curricula, refine credentialing frameworks, and reassess capital planning to align with a landscape that increasingly values precision, safety, and operational efficiency.

Supply chain resilience and procurement strategies reshaped by United States tariff adjustments, driving supplier diversification and regional manufacturing responses across device ecosystems

The cumulative impact of United States tariff adjustments in 2025 has reverberated across global medical device supply chains, compelling manufacturers and healthcare providers to reassess sourcing and procurement strategies for endobronchial ultrasound biopsy devices. Tariff-driven increases in component import costs have created upward pressure on manufacturing expenses, particularly for firms that rely on cross-border production of critical subassemblies and specialized ultrasound transducers. Firms responded by accelerating supplier diversification, shifting to regional vendors where feasible, and, in some cases, reprioritizing local manufacturing investments to mitigate future policy volatility.

On the clinical procurement side, acute awareness of tariff risk has prompted hospital systems and group purchasing organizations to negotiate longer-term supply contracts and to emphasize total cost of ownership in purchasing decisions. These negotiations increasingly consider consumable availability and aftermarket support as essential elements of device value. In parallel, manufacturers have sought to absorb some cost burdens through process improvements, lean manufacturing, and design choices that reduce reliance on tariff-impacted inputs.

Finally, regulatory and contracting teams have become more vigilant in modeling supplier continuity and in requiring transparent disclosure of sourcing footprints. For stakeholders, the tariff landscape underscores the importance of scenario planning, diversified supplier networks, and contract clauses that address cost pass-through to maintain predictable access to endobronchial ultrasound biopsy devices and related consumables.

In-depth segmentation perspective illuminating how product types, offerings, end users, applications, and clinical indications uniquely influence device selection and adoption

Segmentation analysis reveals distinct performance drivers and adoption pathways when the market is examined through product type, product offering, end user, application, and clinical indication lenses. By product type, the field differentiates devices that utilize linear probes, which afford direct visualization for guided needle aspiration of mediastinal and hilar nodes, and radial probes, which excel at peripheral lesion localization and enable complementary diagnostic strategies. When viewed by product offering, equipment investments-such as imaging workstations and scope systems-anchor capital planning and integration costs, while consumables, including needle sets and protective sheaths, shape recurrent spending and procedural throughput.

End-user contexts further nuance adoption dynamics: ambulatory surgical centers prioritize compact, efficient systems and streamlined consumables to support high-throughput outpatient procedures; hospitals emphasize advanced imaging capabilities, broad device interoperability, and comprehensive service agreements; and specialty clinics seek cost-effective configurations that balance diagnostic performance with space and staffing constraints. Applications span mediastinal staging, which demands high precision and reproducibility for staging decisions; peripheral lesion diagnosis, where lesion accessibility and imaging resolution are decisive; and transbronchial needle aspiration, which combines imaging and tissue acquisition and stresses needle design and sampling ergonomics.

Finally, clinical indications-ranging from cancer diagnostics to infectious disease evaluation and sarcoidosis assessment-influence both device selection and procedural protocols, as tissue adequacy, sample handling, and downstream molecular testing requirements vary substantially across these diagnostic pathways.

Regional adoption patterns and commercial imperatives across the Americas, Europe, Middle East & Africa, and Asia-Pacific that shape deployment, training, and aftermarket strategies

Regional dynamics exert a pronounced influence on adoption patterns, regulatory expectations, and commercial strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, a concentration of advanced tertiary care centers and robust interventional pulmonology programs supports early adoption of integrated imaging workstations and advanced scope systems, while payers increasingly scrutinize procedural pathways for cost-effectiveness and outcome alignment. Transitioning procedures to ambulatory surgical settings is creating new procurement priorities centered on mobility, ease of use, and consumable lifecycle management.

Within Europe, Middle East & Africa, heterogeneous regulatory environments and variable hospital funding models drive a mixture of centralized hospital deployments and targeted specialty clinic adoption. Manufacturers often tailor their market entry strategies to national reimbursement frameworks and to regional training partnerships with clinical societies. The Asia-Pacific region demonstrates accelerated uptake in urban tertiary centers and an expanding installed base driven by investments in cancer diagnostics infrastructure, with localized manufacturing and regional distribution partnerships playing pivotal roles in cost control and service responsiveness.

Across these regions, common themes emerge: emphasis on clinician training, the importance of service and warranty ecosystems, and the strategic role of consumables management in sustaining procedural volume. Decision-makers should therefore evaluate regional regulatory pathways, reimbursement nuances, and local clinical practice patterns when planning market entry or expansion.

Competitive landscape analysis highlighting divergent strategic models from integrated platform providers to consumable specialists and the implications for procurement and clinical adoption

Key companies within the endobronchial ultrasound biopsy ecosystem demonstrate a range of strategic approaches, from platform-integrated offerings to consumable-focused business models. Established endoscope manufacturers have leaned into system-level differentiation, combining high-resolution imaging workstations with modular scope architectures to capture procedural ecosystems and to drive consumable attachment. These firms emphasize long-term service contracts, clinician training programs, and bundled solutions that facilitate hospital integration and simplify procurement conversations.

Simultaneously, specialized manufacturers of needle systems and protective sheaths prioritize engineering focused on sampling reliability, tissue integrity, and single-use convenience. Their commercial strategies center on clinical evidence that demonstrates improved diagnostic yield and reduced repeat procedure rates, supported by targeted educational initiatives for interventional pulmonologists and cytopathology teams. Newer entrants and niche innovators often focus on adjunct technologies-such as navigation aids, biopsy forceps, or AI-enabled image enhancement-seeking strategic partnerships with platform holders to accelerate clinical adoption.

Overall, competitive dynamics are shaped by a balance between integrated platforms that lock in recurring consumable revenue and specialist suppliers that win on clinical performance and cost-efficient single-use designs. For purchasers, this dynamic increases the importance of evaluating total contractual arrangements, service level agreements, and the long-term roadmap for interoperability and software support.

Practical and high-impact strategic actions for manufacturers and healthcare providers to enhance clinical adoption, supply chain resilience, and long-term device value

Industry leaders seeking to strengthen market position and support sustainable clinical adoption should pursue a set of actionable strategies that align innovation with operational realities. First, prioritize end-to-end integration between scope systems and imaging workstations to deliver seamless clinical workflows and to reduce clinician friction at the point of care. Embedding robust training curricula and simulation-based credentialing will accelerate proficiency and minimize variability in biopsy technique, thereby improving sample quality and clinician confidence.

Second, develop resilient supply chains by diversifying component sourcing and by investing in regional manufacturing or assembly capabilities where feasible to mitigate trade and tariff exposure. Third, align commercial models with clinical workflows by offering flexible procurement options that address capital constraints, such as subscription-based access to imaging workstations combined with predictable consumable pricing. Fourth, invest in post-market evidence generation that demonstrates the impact of devices on diagnostic yield, downstream treatment decision-making, and patient experience, thereby supporting reimbursement discussions and hospital formulary inclusion.

Finally, foster interoperability and open data architectures to enable integration with electronic health records and multidisciplinary care platforms. These steps collectively will help firms and health systems navigate evolving clinical expectations, regulatory scrutiny, and fiscal pressures while expanding access to advanced endobronchial ultrasound biopsy capabilities.

Robust mixed-methods research approach integrating expert interviews, clinical literature review, and triangulated data analysis to validate insights and limit bias

The research methodology underpinning this analysis combined rigorous primary and secondary research techniques to ensure analytic depth and validity. Primary data collection included structured interviews with interventional pulmonologists, biomedical engineers, procurement leaders, and hospital administrators to capture real-world experiences with device performance, training needs, and consumable logistics. These expert inputs informed assessments of clinical workflows, device ergonomics, and procedural bottlenecks.

Secondary research encompassed a review of peer-reviewed clinical publications, device labeling and regulatory filings, clinical society guidelines, and publicly available regulatory communications to corroborate safety and efficacy claims and to map technology trends. Data triangulation ensured that insights reflected convergent evidence across sources, and sensitivity analyses were applied where qualitative inputs varied among experts. Segment definitions and regional analyses were constructed to align with clinical practice patterns, reimbursement frameworks, and supply chain geographies.

Limitations of the methodology include evolving regulatory landscapes and the pace of technological innovation, both of which can alter device capabilities and adoption dynamics. To address this, the research team applied conservative interpretation of nascent technologies and prioritized peer-reviewed evidence where available. Ethical considerations included anonymizing interview participants and securing consent for the use of proprietary insights in aggregate analysis.

Synthesis of strategic takeaways emphasizing technological progress, supply chain adaptation, and coordinated clinical strategies to maximize diagnostic outcomes

In conclusion, endobronchial ultrasound biopsy devices occupy a strategic position at the intersection of diagnostic precision, procedural safety, and operational efficiency. Technological innovations in probe design, imaging workstations, and single-use consumables are improving diagnostic performance while reshaping how procedures are delivered across ambulatory surgical centers, hospitals, and specialty clinics. At the same time, external pressures such as tariff-induced supply chain adjustments and evolving reimbursement practices are prompting manufacturers and providers to rethink sourcing, pricing, and commercialization models.

Successful deployment requires a holistic view that considers device interoperability, clinician training, consumable lifecycle management, and post-market evidence generation. By aligning product development with real-world clinical workflows and by establishing resilient supply chains, stakeholders can accelerate adoption while managing total cost of ownership and regulatory expectations. Ultimately, the balance between integrated platforms and high-performance consumables will determine how institutions structure purchasing decisions and how clinicians deliver consistent, high-quality diagnostic outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing adoption of linear endobronchial ultrasound devices integrated with real-time imaging guidance for improved lymph node sampling accuracy
  • 5.2. Development of single-use disposable ultrasound probes aiming to reduce infection risk and lower sterilization costs in endobronchial biopsy procedures
  • 5.3. Advancements in needle design featuring variable gauge and adjustable stiffness for enhanced access to difficult airway lesions during EBUS biopsies
  • 5.4. Increasing use of artificial intelligence and machine learning algorithms for automated lymph node detection and malignancy prediction during EBUS procedures
  • 5.5. Expansion of hybrid operating rooms equipped with EBUS and endoscopic navigational bronchoscopy systems to streamline diagnosis and therapy workflows
  • 5.6. Collaboration between medical device manufacturers and software companies to develop cloud-based EBUS data management and tele-mentoring platforms
  • 5.7. Rising demand for minimally invasive EBUS-guided cryobiopsy techniques for the safe collection of larger tissue specimens in interstitial lung disease diagnosis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endobronchial Ultrasound Biopsy Devices Market, by Product Type

  • 8.1. Linear Probe
  • 8.2. Radial Probe

9. Endobronchial Ultrasound Biopsy Devices Market, by Product Offering

  • 9.1. Consumables
    • 9.1.1. Needle Sets
    • 9.1.2. Protective Sheaths
  • 9.2. Equipment
    • 9.2.1. Imaging Workstations
    • 9.2.2. Scope Systems

10. Endobronchial Ultrasound Biopsy Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Specialty Clinics

11. Endobronchial Ultrasound Biopsy Devices Market, by Application

  • 11.1. Mediastinal Staging
  • 11.2. Peripheral Lesion Diagnosis
  • 11.3. Transbronchial Needle Aspiration

12. Endobronchial Ultrasound Biopsy Devices Market, by Indication

  • 12.1. Cancer Diagnostics
  • 12.2. Infectious Diseases
  • 12.3. Sarcoidosis

13. Endobronchial Ultrasound Biopsy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endobronchial Ultrasound Biopsy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endobronchial Ultrasound Biopsy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Olympus Corporation
    • 16.3.2. Fujifilm Holdings Corporation
    • 16.3.3. HOYA Corporation
    • 16.3.4. Boston Scientific Corporation
    • 16.3.5. Medtronic plc
    • 16.3.6. Karl Storz SE & Co. KG

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 261. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 262. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 263. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 269. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 274. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 275. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 276. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025